Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Beatriz Rojas

1PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 07, 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.

Peter Schmid, Nicholas C Turner, Carlos H Barrios

Pageof 1

Frequent Collaborators

1 joint publications

Peter Schmid

1 joint publications

Nicholas C Turner

1 joint publications

Carlos H Barrios

1 joint publications

Steven J Isakoff

1 joint publications

Sung-Bae Kim

1 joint publications

Marie-Paule Sablin

1 joint publications

Shigehira Saji

1 joint publications

Peter Savas

1 joint publications

Gregory A Vidal

1 joint publications

Mafalda Oliveira

Frequent Collaborators

1 joint publications

Peter Schmid

1 joint publications

Nicholas C Turner

1 joint publications

Carlos H Barrios

1 joint publications

Steven J Isakoff

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.0K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.0K
See more related videos